Award

Purchase of Stereotactic Neurosurgery Systems

  • UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST

UK5: Transparency notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-058869

Procurement identifier (OCID): ocds-h6vhtk-05a013 (view related notices)

Published 23 September 2025, 12:23pm



Scope

Description

We are procuring 3 Stereotactic Neurosurgery systems and 1 frame with associated accessories.


Contract 1. Purchase of Stereotactic Neurosurgery Systems, Frame and Associated Accessories

Supplier

Contract value

  • £191,000 excluding VAT
  • £229,046 including VAT

Above the relevant threshold

Earliest date the contract will be signed

4 October 2025

Contract dates (estimated)

  • 5 October 2025 to 4 November 2025
  • 1 month

Main procurement category

Goods

CPV classifications

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

Contract locations

  • UK - United Kingdom

Participation

Particular suitability

Small and medium-sized enterprises (SME)


Other information

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Direct award

Direct award justification

Single supplier - technical reasons

The Leksell Vantage frame is essential for stereotactic neurosurgical procedures at NHNN as it is the only product that meets the specific clinical and technical requirements of the service. This minimally invasive specialty requires extreme precision to localise and treat very small targets deep within the brain.

The Vantage frame uniquely enables intraoperative MRI and CT scanning and provides sub-millimetre accuracy. Having multiple different systems in situ would present significant clinical risk (due to different workflows), inequality of service delivery (patients receiving varying levels of accuracy), and increased governance risk.

The Vantage frame also facilitates easier anaesthesia, improves communication during awake neurosurgical procedures, and allows the patients' head and frame to remain mobile during surgery under local anaesthetic - directly improving patient safety and experience.

The Leksell Vantage solution has a proven international track record and is supported by extensive published evidence demonstrating successful outcomes in DBS surgery. It is the only solution fully integrated with Trust MRI and CT scanners, ensuring seamless operation within the current infrastructure. It is also compatible with existing stereotactic accessories, arc systems, planning software, and other non-sterile workflow components.

Remaining with a single, standardised platform will minimise training requirements, reduce procedural errors, and support higher surgical throughput, ensuring the service can continue to run safely and efficiently.


Supplier

SEVERN HEALTHCARE TECHNOLOGIES LIMITED

  • Companies House: 08257059
  • Public Procurement Organisation Number: PYTN-2411-BGWR

Woodland House Blackwood Hall Business Park

Selby

YO8 5DD

United Kingdom

Region: UKE22 - North Yorkshire CC

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Contract 1. Purchase of Stereotactic Neurosurgery Systems, Frame and Associated Accessories


Contracting authority

UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST

  • NHS Organisation Data Service: RRV
  • Public Procurement Organisation Number: PYRL-5371-BNMH

250 Euston Road

London

NW1 2PG

United Kingdom

Region: UKI31 - Camden and City of London

Organisation type: Public authority - central government